Erik Magnus Ohman, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Medscape(SIGNIFICANT), Abiomed(SIGNIFICANT), Milestone Pharmaceuticals(SIGNIFICANT), Xylocor Therapeutics(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Chiesi(SIGNIFICANT), Abiomed(SIGNIFICANT)

View Full Disclosure